Resilience in Pediatric Oncology and the Clinical Challenges of Recurrent Neuroblastoma as Exemplified by the Case of Two-Year-Old Lily
The medical journey of two-year-old Lily, a child twice diagnosed with neuroblastoma, serves as a...
Knowledge and News for the Global Fight Against Cancer.
The medical journey of two-year-old Lily, a child twice diagnosed with neuroblastoma, serves as a...
The landscape of pediatric neuro-oncology is witnessing a significant shift as a groundbreaking clinical trial...
Memorial Sloan Kettering Cancer Center researcher Kathryn Taylor, PhD, has been named the latest recipient...
A kidney cancer diagnosis, historically a harbinger of profound uncertainty and fear, is increasingly met...
Ugur Sahin and Özlem Türeci, the visionary co-founders who meticulously steered BioNTech from a nascent...
For over 70 years, the Cancer Research Institute (CRI) has stood at the vanguard of...
The biopharmaceutical industry is currently a hotbed of activity, marked by significant regulatory milestones, innovative...
Basel, Switzerland – Hopes for Roche’s amylin-targeting obesity drug, petrelintide, have been tempered following the...
French pharmaceutical giant Servier has reached a definitive agreement to acquire Day One Biopharmaceuticals, a...
A cervical cancer diagnosis, historically fraught with profound uncertainty and fear, is now being met...